01 1Creative Actives Private Limited
01 1Pharmapia Co., Ltd.
01 1Sodium picosulfate hydrate
01 1Blank
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2025-08-26
Registration Number : 20250826-211-J-1997
Manufacturer Name : Creative Actives Private Lim...
Manufacturer Address : Plot No. 15B6, APSEZ De-Notified Area, Atchuthapuram, Krishnapalem (V), Rambili (M), ...
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
49
PharmaCompass offers a list of Sodium Picosulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sodium Picosulfate manufacturer or Sodium Picosulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Picosulfate manufacturer or Sodium Picosulfate supplier.
A Laxoberon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Laxoberon, including repackagers and relabelers. The FDA regulates Laxoberon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Laxoberon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Laxoberon manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Laxoberon supplier is an individual or a company that provides Laxoberon active pharmaceutical ingredient (API) or Laxoberon finished formulations upon request. The Laxoberon suppliers may include Laxoberon API manufacturers, exporters, distributors and traders.
click here to find a list of Laxoberon suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Laxoberon Drug Master File in Korea (Laxoberon KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Laxoberon. The MFDS reviews the Laxoberon KDMF as part of the drug registration process and uses the information provided in the Laxoberon KDMF to evaluate the safety and efficacy of the drug.
After submitting a Laxoberon KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Laxoberon API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Laxoberon suppliers with KDMF on PharmaCompass.
